Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367172 · ClinicalTrials.gov registry record · NA
Directly Observed Antiretroviral Therapy Among Active Drug Users
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT00367172 is a NA study that has completed, run by Yale University. The registered enrollment target is 125 participants.
The verdict
NCT00367172, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The goal of this randomized, controlled trial is to compare the effectiveness of a community-based program of providing supervised antiretroviral therapy to HIV-positive drug users, compared to having the patients take the medicines on their own.
Interventions
- BEHAVIORAL Directly Administered Antiretroviral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2001-06 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00367172
The ClinicalTrials.gov registry entry for NCT00367172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Directly Administered Antiretroviral Therapy is the first listed.
NCT00367172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00367172 about?
NCT00367172 is a clinical study titled "Directly Observed Antiretroviral Therapy Among Active Drug Users". The goal of this randomized, controlled trial is to compare the effectiveness of a community-based program of providing supervised antiretroviral therapy to HIV-positive drug users, compared to having the patients take the medicines on their own.
What is the current status of trial NCT00367172?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2001-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00367172?
The interventions under investigation include: Directly Administered Antiretroviral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00367172?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.